Skip to main content

Table 1 Demographic characteristics of treated patients (N = 400).

From: A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients

Characteristics

Genotype 1

(N = 70)

Genotype 2

(N = 33)

Genotype 3

(N = 260)

Other Genotypes

(N = 6) *

Mixed Genotypes

(N = 31)

Sex-No. (%)

     

Male

47 (67.1)

22 (66.7)

185 (71.2)

6 [100]

20 (64.5)

Female

23 (32.9)

11 (33.3)

75 (28.8)

0 [0]

11 (35.5)

Age range-years

     

Mean age (Y)

25–70

21–68

18–55

20–57

21–60

± SD

50 ± 9.5

48 ± 9.0

45 ± 10.2

49 ± 9.8

46 ± 8.4

Ethnic group-No. (%)

     

Panjabi

50 (71.4)

21 (63.6)

203 (78.1)

4 (66.7)

21 (67.7)

Pashtoons

15 (21.4)

10 (30.3)

41 (15.8)

2 (33.3)

10 (32.3)

Balochi

3 (4.2)

1 (3.0)

7 (2.7)

0

0

Sindhi

2 (2.9)

1 (3.0)

9 (3.4)

0

0

Pre-treatment HCV RNA level

     

< 200,000 IU/mL

22 (31.4%)

11 (33.3)

71 (27.3)

1 (16.7)

4 (12.9)

> 200,000 IU/mL

48 (68.6)

22 (66.7)

189 (72.7)

5 (83.3)

27 (87.1)

Cirrhosis-No (%)

     

Present

3 (4.3)

2 (6.1)

9 (3.5)

0 [0]

2 (6.5)

Absent/unknown

67 (95.7)

31 (93.9)

251 (96.5)

6 [100]

29 (93.5)

  1. *Of the patients with other genotypes, 4 had HCV genotype 4 and one each was with genotype 5a and 6a.
  2. Out of 31 patients with mixed genotypes, 13 were with genotypes 3a+3b; 4 with 2a+3b; 3 each with 2a+3a & 1a+1b, 2 each with 1a+3a & 3a+4; 1 each with 1a+3c, 1b+2a, 1c+3b & 1c+3c.
  3. SD, standard deviation.